William E. Rote, Senior Vice President, R&D at Travere Therapeutics, Inc. (TVTX), sold 1,407 shares at $17.12 ($24K) on 2021-08-17, disclosed to the SEC on 2021-08-17.
Open-market sale of $24k TVTX by Senior Vice President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2026-04-23 | $356K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $409K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $2.4M | — | Filing → |